Hence, our findings provide novel molecular insights into how the genetic determinant GSDMB regulates lung inflammation in asthma development, suggesting a promising therapeutic strategy for treating airway inflammation in genetically susceptible asthmatics. Here, GSDMB is linked to asthma.